Yarrow Bioscience Inc YARW
18.37 USD +0.44 (+2.45%)
At closeNov 3, 2026, 4:00 PM EST
18.37 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
16.71 Day range 18.86
16.05 52-week range 46.95
- YTD
- -36.66%
- 1 year
- +6.18%
- Market cap
- 170.92M
- YTD return
- -36.66%
- 1-year return
- +6.18%
- Volume
- 258.95K
- Avg volume
- 120.65K
- Open
- 17.74
- Previous close
- 17.93
- Day's range
- 16.71 – 18.86
- 52-week range
- 16.05 – 46.95
2Y -131.28 (-87.81%)
Financials — quick view
YARW Revenue — quarterly 97.00K
YARW Net income — quarterly -3.01M
YARW EPS — quarterly -3.51
News
Yarrow Bioscience Announces Participation in November Investor Events 
Contrasting Yarrow Bioscience (NASDAQ:YARW) and Atara Biotherapeutics (NASDAQ:ATRA) 
Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares 
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering 
Yarrow Bioscience Announces Proposed Underwritten Public Offering 
Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update 
Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves' Disease and Thyroid Eye Disease 
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience 
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience 
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
Your note
Sign in to keep a note on YARW — it syncs with the Stock Master app.